Suppression of Activation of the Human Immunodeficiency Virus Long Terminal Repeat by CD8+ T Cells Is Not Lentivirus Specific

AIDS Research and Human Retroviruses

Volumn 11, Issue 11, 1995, Pages 1321-1326

  Copeland, Karen F T ^a   Mckay, Paula J ^a   Rosenthal, Kenneth L ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SPECIFICITY; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS GENE;

CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 2, SAIMIRIINE; HIV; HIV LONG TERMINAL REPEAT; HUMAN; LENTIVIRUS; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION, GENETIC;

EID: 0028856829     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1995.11.1321     Document Type: Article

References (43)

1. Walker CM, Moody DJ, Stites DP, and Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
2. Brinchmann JE, Gaudemack G, and Vartdal F: CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells: Evidence for a soluble inhibitor. J Immunol 1990;144:2961-2966.
3. Walker CM and Levy JA: A diffusable lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 1989;66:628-630.
4. Tsubota H, Lord CJ, Watkins DJ, Morimoto C, and Letvin NL: A cytotoxic T lymphocyte inhibits acquired immunodeficiency virus replication in peripheral blood lymphocytes. J Exp Med 1989;169:1421-1434.
5. Walker CM, Erickson AL, Hsueh FC, and Levy JA: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J Virol 1991;65:5921-5927.
6. Castro BA, Walker CM, Eichberg JW, and Levy JA: Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. Cell Immunol 1991; 132:246-255.
7. Gomez AM, Smaill FM, and Rosenthal KL: Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clin Exp Immunol 1994;97:68-75.
8. Landay AL, Mackewicz CE, and Levy JA: An activated T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993;69:106-116.
9. Bagasra O and Pomerantz RJ: The role of CD8-positive lymphocytes in the control of HIV-1 infection of peripheral blood mononuclear cells. Immunol Lett 1993;35:83-92.
10. Walker CM, Thomson-Honnebier GA, Hsueh FC, Erickson AL, Pan L, and Levy JA: CD8+ cells from HTV infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 1991; 137:420-428.
11. Powell JD, Bednarik DP, Folks TM, Jehuda-Cohen T, Villinger F, Sell KW, and Ansari AA: Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from nonhuman primates. Clin Exp Immunol 1993,91:473-481.
12. Ennen J, Findekelle H, Dittmar MT, Norley S, Ernst M, and Kurth R: CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci USA 1994;91:7207-7211.
13. Husch B, Eibl MM, and Mannhalter JW: CD3, CDS double-positive cells from HIV-1-infected chimpanzees show group-specific inhibition of HIV-1 replication. AIDS Res Hum Retroviruses 1993;9:405-413.
14. Knuchel M, Bednarik DP, Chikkala N, and Ansari A A: Biphasic in vitro regulation of retroviral replication by CD8+ cells from nonhuman primates. J AIDS 1994;7:438-446.
15. Chen C-H, Weinhold KJ, Bartlett JA, Bolognesi DP, and Greenberg M: CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: A novel antiviral mechanism. AIDS Res Hum Retroviruses 1993;9:1079-1086.
16. Mackewicz CE, Blackboum DJ, and Levy JA: CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
17. Biesinger B, Muller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E, Desrosiers RC, and Fleckenstein B: Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc Natl Acad Sci USA 1992;89:3116-3119.
18. Berkhout B, Silverman RH, and Jeang K-T: Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989;59:273-282.
19. Copeland KFT, Haaksma AGM, Derse D, Goudsmit J. and Heeney JL: Cytochemical analysis of human T-cell leukaemia LTR-regu-lated beta-galactosidase gene expression using a novel integrated cell system. J Virol Methods 1993;45:161-167.
20. Copeland KFT, Haaksma AGM, Goudsmit J, and Heeney JL: Inhibition of phorbol ester- and tax-mediated ira/i5-activation of the human T-cell leukaemia virus 1 long terminal repeat by iono-mycin. J Gen Virol 1994;75:1623-1631.
21. Peterlin M, Luciw PA, Barr JP, and Walker MD: Elevated levels of mRNA can account for the transactivation of human immunodeficiency virus (HIV). Proc Natl Acad Sci USA 1986;83: 9734-9738.
22. Pierce JW, Lenardo M, and Baltimore D: Oligonucleotide that binds nuclear factor NFkB acts as a lymphoid-specific and inducible enhancer element. Proc Natl Acad Sci USA 1988;85: 1482-1486.
23. Gorman CM, Merlino GT, Willingham MC, Pastan I, and Howard BH: The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci USA 1982;79: 6777-6781.
24. Queen C and Baltimore D: Immunoglobuhn gene transcription is activated by downstream sequence elements. Cell 1983; 33:741-748.
25. Herbomel P, Bourachof B, and Yaniv M: Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 1984;39:653-661.
26. Schirm S, Muller I, Desrosiers RC, and Fleckenstein B: Herpesvirus saimiri DNA in a lymphoid cell line established by in vitro transformation. J Virol 1984;49:938-946.
27. Mackewicz C and Levy JA: CD8+ cell anti-HTV activity: Non-lytic suppression of virus replication. AIDS Res Hum Retroviruses 1992;8:1039-1050.
28. Mackewicz CE, Ortega HW, and Levy JA: Effect of cytokines on HIV replication in CD4+ lymphocytes. Cell Inmiunol 1994;153:329-343.
29. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, and Fauci AS: Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 1991;173:589-597.
30. Chowdhury IH, Koyanagi Y, Hazeki O, Ui M, and Yamamoto N: Pertussis toxin inhibits induction of human immunodeficiency virus type 1 in infected monocytes. Virology 1994;203:378-383.
31. Zarling JM, Moran PA, Haffar O, Sias J. Richman DD, Spina CA, Myers DE, Kuebelbeck V, Ledbetter JA, and Uckun FM: Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature (London) 1990;347:92-95.
32. Margolis DM, Somasundaran M, and Green MR: Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production. J Virol 1994;68:905-910.
33. Perkins ND, Agranoff AB, Duckett CS, and Nabel GJ: Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression. J Virol 1994;68:6820-6823.
34. Duan L, Ozaki I, Oakes JW, Taylor P, Khalili K, and Pomerantz RJ: The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994;68: 4302-4313.
35. Brinchmann JE, Gaudemack G, and Vartal F: In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rlFN gamma, or recombinant tumor necrosis factor alpha. AIDS 1991;4:480-488.
36. Montaner LJ, Griffin P, and Gordon S: Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J Gen Virol 1994;75:3393-3400.
37. Weissman D, Poli G, and Fauci AS: Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor a and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 1994;10:1199-1206.
38. Orchard K, Lang G, Collins M, and Latchman D: Characterization of a novel T lymphocyte protein which binds to a site related to steroid/thyroid hormone receptor response elements in the negative regulatory sequence of the human immunodeficiency virus long terminal repeat. Nucleic Acids Res 1992;20:5429-5434.
39. Orchard K, Perkins N, Chapman C, Harris J, Goodwin G, Latchman D, and Collins M: A novel T-cell protein which recognizes a palindromic sequence in the negative regulatory element of the human immunodeficiency virus long terminal repeat. J Virol 1990;64: 3234-3239.
40. Fletcher MA, Klimas NG, Walling J, Patarca R, Albarracin C, Mayer V, Garcia-Morales R, Gamber C, Moody D, and Ocarma T: Phase 1 trial of adoptive therapy with purified CD8 cells in HIV infection: Properties of the ex vivo expanded cells. Abstract PoB 3444, VIII International Conference on AIDS. Amsterdam, 1992.
41. Ho M, Armstrong J, McMahon D, Pazin G, Huang X-L, Rinaldo C, Whiteside T, Tripoli C, Levine G, Moody D, Okarma T, Elder E, Gupta P, Tauxe N, Torpey D, and Herberman R: A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. Blood 1993;81:2093-2101.
42. Klimas NG, Patarca R, Walling J, Garcia R, Mayer V, Moody D, Ocarma T, and Fletcher MA: Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion. AIDS 1994; 8:1073-1081.
43. Tauxe N, Ho M, Levine J, McMahon D. Elder E, Whiteside T, and Moody D: Distribution and trafficking of autologous expanded CD8+ cells infused in subjects with ARC or AIDS. Abstract PoB 3452 VIII International Conference on AIDS, Amsterdam, 1992.